
Alctin 100mg Injection
Marketer
All Molecules
Salt Composition
Levetiracetam (100mg)
Overview Alctin 100mg Injection
Epileptic seizures are managed with the anticonvulsant injection, Alctin 100mg. Administered intravenously as a slow infusion by a healthcare professional, it provides short-term seizure control when oral medication is impractical, such as during unconsciousness. This medication's effectiveness relies on continuous use; halting treatment may exacerbate seizures. Alctin 100mg is typically a bridge to long-term oral anti-epileptic therapy. While generally well-tolerated, potential side effects include drowsiness, headache, infection, local irritation, nasal congestion, and altered behavior (including aggression and appetite changes). These usually subside; however, immediate medical attention is warranted for allergic reactions (rash, hives, breathing difficulty, swelling), persistent behavioral changes (confusion, irritability), or suicidal ideation. Inform your physician of pre-existing kidney disease, depression, suicidal thoughts, or pregnancy before commencing treatment. Alcohol consumption should be avoided due to increased seizure risk and potentiation of side effects. Drowsiness and dizziness may impair driving or operating machinery. Regular kidney function monitoring may be necessary during treatment.
Primary Ingredients of Alctin 100mg Injection
No information provided. A rephrased text cannot be generated without the original text.
Uses of Alctin 100mg Injection
Managing Epileptic Seizures
Major Benefits of Alctin 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Alctin 100mg Injection:
- Sleepiness
- Dizziness
- Decreased appetite
- Fatigue
- Headache
- Behavioral changes
- Irritation
- Aggressive behavior
- Agitation
- Infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Alctin 100mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Alctin 100mg Injection works:
NeuroBloc 100mg injection, an anticonvulsant, targets synaptic vesicle protein 2A (SV2A) receptors on neuronal membranes. This action diminishes aberrant neuronal firing in the brain, thus preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Alctin 100mg Injection.
PregnancyCONSULT YOUR DOCTOR
The use of Alctin 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Alctin 100mg Injection during lactation appears to pose minimal risk. Available human data indicate negligible infant harm. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Administration of Alctin 100mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, administering Alctin 100mg Injection requires careful consideration. A modified dosage of Alctin 100mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Alctin 100mg Injection in individuals with liver impairment is likely safe. Current evidence indicates dose modification might be unnecessary for most; however, patients with advanced liver disease may benefit from a reduced dosage. Physician consultation is recommended.
What if you forget to take Alctin 100mg Injection :
Should you forget a dose of Alctin 100mg Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Alctin 100mg Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Category | AED: A protein ligand bound to synaptic vesicle 2 |
